India's COVID-19 vaccine -- Covaxin -- will be evaluated as a vaccine candidate in the United States, Bharat Biotech said on Saturday, 19 February.
(Image: Erum Gour/The Quint)
India's COVID-19 vaccine – Covaxin – will be evaluated as a vaccine candidate in the United States, Bharat Biotech said on Saturday, 19 February.
Covaxin is India's indigenous COVID-19 vaccine manufactured by Bharat Biotech, which has been developed in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV).
Ocugen is co-developing Bharat Biotech's Covaxin in the US and Canada.
It was given emergency use approval by the Drugs Controller General of India (DCGI) for the 12-18 age group on 24 December 2021.
(Edited for language.)
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)